486 related articles for article (PubMed ID: 24812504)
21. Serum cytokine profiling and enrichment analysis reveal the involvement of immunological and inflammatory pathways in stable patients with chronic obstructive pulmonary disease.
Bade G; Khan MA; Srivastava AK; Khare P; Solaiappan KK; Guleria R; Palaniyar N; Talwar A
Int J Chron Obstruct Pulmon Dis; 2014; 9():759-73. PubMed ID: 25125975
[TBL] [Abstract][Full Text] [Related]
22. New therapies for chronic obstructive pulmonary disease.
Barnes PJ
Med Princ Pract; 2010; 19(5):330-8. PubMed ID: 20639653
[TBL] [Abstract][Full Text] [Related]
23. Systemic and Tumor Th1 and Th2 Inflammatory Profile and Macrophages in Lung Cancer: Influence of Underlying Chronic Respiratory Disease.
Mateu-Jimenez M; Curull V; Pijuan L; Sánchez-Font A; Rivera-Ramos H; Rodríguez-Fuster A; Aguiló R; Gea J; Barreiro E
J Thorac Oncol; 2017 Feb; 12(2):235-248. PubMed ID: 27793775
[TBL] [Abstract][Full Text] [Related]
24. The development of AZD7624 for prevention of exacerbations in COPD: a randomized controlled trial.
Patel NR; Cunoosamy DM; Fagerås M; Taib Z; Asimus S; Hegelund-Myrbäck T; Lundin S; Pardali K; Kurian N; Ersdal E; Kristensson C; Korsback K; Palmér R; Brown MN; Greenaway S; Siew L; Clarke GW; Rennard SI; Make BJ; Wise RA; Jansson P
Int J Chron Obstruct Pulmon Dis; 2018; 13():1009-1019. PubMed ID: 29628759
[TBL] [Abstract][Full Text] [Related]
25. Emerging drugs for asthma.
Walsh GM
Expert Opin Emerg Drugs; 2008 Dec; 13(4):643-53. PubMed ID: 19046132
[TBL] [Abstract][Full Text] [Related]
26. New Perspectives for Mucolytic, Anti-inflammatory and Adjunctive Therapy with 1,8-Cineole in COPD and Asthma: Review on the New Therapeutic Approach.
Juergens LJ; Worth H; Juergens UR
Adv Ther; 2020 May; 37(5):1737-1753. PubMed ID: 32200535
[TBL] [Abstract][Full Text] [Related]
27. Innate immunity but not NLRP3 inflammasome activation correlates with severity of stable COPD.
Di Stefano A; Caramori G; Barczyk A; Vicari C; Brun P; Zanini A; Cappello F; Garofano E; Padovani A; Contoli M; Casolari P; Durham AL; Chung KF; Barnes PJ; Papi A; Adcock I; Balbi B
Thorax; 2014 Jun; 69(6):516-24. PubMed ID: 24430176
[TBL] [Abstract][Full Text] [Related]
28. Resveratrol impairs the release of steroid-resistant inflammatory cytokines from human airway smooth muscle cells in chronic obstructive pulmonary disease.
Knobloch J; Sibbing B; Jungck D; Lin Y; Urban K; Stoelben E; Strauch J; Koch A
J Pharmacol Exp Ther; 2010 Dec; 335(3):788-98. PubMed ID: 20801891
[TBL] [Abstract][Full Text] [Related]
29. Systems pharmacology-based approach for dissecting the active ingredients and potential targets of the Chinese herbal Bufei Jianpi formula for the treatment of COPD.
Zhao P; Li J; Li Y; Tian Y; Wang Y; Zheng C
Int J Chron Obstruct Pulmon Dis; 2015; 10():2633-56. PubMed ID: 26674991
[TBL] [Abstract][Full Text] [Related]
30. Correlation of severity of chronic obstructive pulmonary disease with potential biomarkers.
Singh S; Verma SK; Kumar S; Ahmad MK; Nischal A; Singh SK; Dixit RK
Immunol Lett; 2018 Apr; 196():1-10. PubMed ID: 29329680
[TBL] [Abstract][Full Text] [Related]
31. Metabolomic fingerprinting and systemic inflammatory profiling of asthma COPD overlap (ACO).
Ghosh N; Choudhury P; Kaushik SR; Arya R; Nanda R; Bhattacharyya P; Roychowdhury S; Banerjee R; Chaudhury K
Respir Res; 2020 May; 21(1):126. PubMed ID: 32448302
[TBL] [Abstract][Full Text] [Related]
32. The cytokine network in chronic obstructive pulmonary disease.
Barnes PJ
Am J Respir Cell Mol Biol; 2009 Dec; 41(6):631-8. PubMed ID: 19717810
[TBL] [Abstract][Full Text] [Related]
33. Development of new drugs for COPD.
Barnes PJ
Curr Med Chem; 2013; 20(12):1531-40. PubMed ID: 22963554
[TBL] [Abstract][Full Text] [Related]
34. Role of eosinophils in airway inflammation of chronic obstructive pulmonary disease.
Tashkin DP; Wechsler ME
Int J Chron Obstruct Pulmon Dis; 2018; 13():335-349. PubMed ID: 29403271
[TBL] [Abstract][Full Text] [Related]
35. Measurement of tumor necrosis factor-alpha, leukotriene B4, and interleukin 8 in the exhaled breath condensate in patients with acute exacerbations of chronic obstructive pulmonary disease.
Ko FW; Leung TF; Wong GW; Ngai J; To KW; Ng S; Hui DS
Int J Chron Obstruct Pulmon Dis; 2009; 4():79-86. PubMed ID: 19436689
[TBL] [Abstract][Full Text] [Related]
36. IL-17A-associated IKK-α signaling induced TSLP production in epithelial cells of COPD patients.
Anzalone G; Albano GD; Montalbano AM; Riccobono L; Bonanno A; Gagliardo R; Bucchieri F; Marchese R; Moscato M; Profita M
Exp Mol Med; 2018 Oct; 50(10):1-12. PubMed ID: 30291224
[TBL] [Abstract][Full Text] [Related]
37. Resveratrol attenuates the release of inflammatory cytokines from human bronchial smooth muscle cells exposed to lipoteichoic acid in chronic obstructive pulmonary disease.
Knobloch J; Wahl C; Feldmann M; Jungck D; Strauch J; Stoelben E; Koch A
Basic Clin Pharmacol Toxicol; 2014 Feb; 114(2):202-9. PubMed ID: 23981542
[TBL] [Abstract][Full Text] [Related]
38. Blocking proinflammatory cytokine release modulates peripheral blood mononuclear cell response to Porphyromonas gingivalis.
Berker E; Kantarci A; Hasturk H; Van Dyke TE
J Periodontol; 2013 Sep; 84(9):1337-45. PubMed ID: 23173823
[TBL] [Abstract][Full Text] [Related]
39. Baicalin alleviates chronic obstructive pulmonary disease through regulation of HSP72-mediated JNK pathway.
Hao D; Li Y; Shi J; Jiang J
Mol Med; 2021 May; 27(1):53. PubMed ID: 34053448
[TBL] [Abstract][Full Text] [Related]
40. Characterization of TLR-induced inflammatory responses in COPD and control lung tissue explants.
Pomerenke A; Lea SR; Herrick S; Lindsay MA; Singh D
Int J Chron Obstruct Pulmon Dis; 2016; 11():2409-2417. PubMed ID: 27729782
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
